Watchlist Price Alert

Enlivex Therapeutics Ltd. (ENLV)

NASDAQ: ENLV · Real-Time Price · USD

1.04

-0.01 (-0.95%)

At close: May 02, 2025, 3:55 PM

1.03

-0.96%

After-hours: May 02, 2025, 05:12 PM EDT

Enlivex Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	3.41M	813K	47.82M	11.2M	5.67M	3.95M	9.74M	3.53M	6.87M
Short-Term Investments	20.2M	26.51M	299K	72.93M	30.03M	8.06M	40K	n/a	3.01M
Long-Term Investments	531K	308K	307K	3K	89K	76K	56K	n/a	11K
Other Long-Term Assets	10K	179K	105K	482K	8K	-329K	16K	38.00	7K
Receivables	1.3M	n/a	n/a	1.09M	n/a	-1.1M	213K	n/a	52K
Inventory	n/a	n/a	1.18M	-12.2M	-31.2M	1.5M	n/a	n/a	n/a
Other Current Assets	198K	5.11M	n/a	1.2M	1.17M	3.5M	n/a	n/a	n/a
Total Current Assets	25.99M	33.76M	52.33M	86.44M	38.12M	16.42M	10.28M	3.62M	10.54M
Property-Plant & Equipment	1.15M	2.58M	14.9M	8.22M	2.14M	1.06M	685K	388.00	71K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	410K	n/a	n/a	n/a
Total Long-Term Assets	1.69M	3.07M	15.31M	8.7M	2.24M	1.14M	757K	426.00	89K
Total Assets	27.69M	36.83M	67.64M	95.15M	40.36M	17.56M	11.03M	3.62M	10.63M
Account Payables	811K	827K	1.95M	878K	463K	316K	173K	19K	32K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	235K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	2.47M	1.57M	n/a	n/a	1.17M	3.4M	n/a	403K	1.5M
Total Current Liabilities	3.8M	6.06M	6.61M	4.72M	4.37M	5.98M	1.13M	460K	1.93M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	-1	n/a	n/a	n/a	499K	n/a	198K	n/a	n/a
Total Long-Term Liabilities	299K	686K	4.19M	5.39M	499K	298K	198K	n/a	n/a
Total Liabilities	4.1M	6.75M	10.8M	10.11M	4.87M	6.28M	1.33M	460K	1.93M
Total Debt	534K	1.03M	4.85M	617K	203K	123K	n/a	n/a	n/a
Common Stock	2.69M	2.14M	2.12M	2.11M	1.65M	1.15M	396K	45K	45K
Retained Earnings	-127.11M	-112.09M	-83.03M	-51.97M	-37.5M	-25.67M	-16.29M	-45.75M	-39.81M
Comprehensive Income	1.1M	1.1M	1.1M	1.1M	977K	-1.3M	-2.25M	-1.5K	-40K
Shareholders Equity	23.59M	30.08M	56.84M	85.04M	35.49M	11.28M	9.71M	3.16M	8.7M
Total Investments	20.73M	26.82M	299K	72.93M	30.03M	8.06M	40K	n/a	3.02M